Characteristics associated with poor COVID-19 outcomes in people with psoriasis, psoriatic arthritis and axial spondyloarthritis: data from the COVID-19 PsoProtect and Global Rheumatology Alliance physician-reported registries

Pedro Machado ,Rebecca Grainger ,Maureen Dubreuil ,Claudia Leoni ,Paul Sufka ,Marcos David Zelaya ,Marcelo M Pinheiro ,D Alpizar-Rodriguez ,Carla Gimena Alonso ,Tor Olofsson ,J Hausmann ,María De Los Ángeles Severina ,Alexander Pfeil ,Nick Dand ,Elsa F Mateus ,Philip C Robinson ,Zenas Z N Yiu ,Dieter Wiek ,Suleman Bhana ,Thao Pham ,Jinoos Yazdany ,Laure Gossec ,H Santos ,Jean W Liew ,Lianne S Gensler ,Francinne Machado Ribeiro ,Jonathan Dau ,Christopher E.m Griffiths ,Corinne Miceli‐Richard ,Lindsay Jacobsohn ,Anja Strangfeld ,F R Martins ,Daniel Wendling ,Nicoletta Romeo ,Rebecca Hasseli ,Nigil Haroon ,Kimme L Hyrich ,Saskia Lawson‐Tovey ,Bruno Fautrel ,Anne C Regierer ,Mark Yates ,Lígia Torres Silva ,Satveer K Mahil ,Carla G S Saad ,Debabrata Bandyopadhyay ,Felipe Omura,Martin Schäfer ,W Bautista-Molano ,Zachary S Wallace ,Loreto Carmona ,Monique Gore-Massy ,Enrique R Soriano ,Emily Sirotich ,Catherine Smith

doi:10.1136/ard-2022-223499

Abstract

ObjectivesTo investigate factors associated with severe COVID-19 in people with psoriasis (PsO), psoriatic arthritis (PsA) and axial spondyloarthritis (axSpA).MethodsDemographic data, clinical characteristics and COVID-19 outcome severity of adults with PsO,...

Full Text